E
Enveda Biosciences
Engineering new drugs from nature with knowledge graphs, metabolomics, and ML
At a glance
- Founded
- 2019
- Headquarters
- Boulder, United States
- Sector
- Biotech & Life Sciences
- Power Law
- Unicorn$1–10B valuation tier
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed4 investors entered at this stage
Village Global
True Ventures- CGChris Gibson
- WVWireframe Ventures
Series A6 investors entered at this stage
- LCLifeforce Capital
- CMCatalio Capital Management
Two Sigma Ventures
Hummingbird Ventures
Lux Capital- MSMatthew De Silva
Series B and later18 investors entered at this stage
- LMLingotto Investment Management
- HKHenry Kravis
Premji Invest
Microsoft- DIDimension
- ACAmino Collective
- LVLevel Ventures
- FVFPV Ventures
- JPJAZZ Venture Partners
Baillie Gifford- PPPeakline Partners
- SASanofi
Kinnevik- SVSocium Ventures
IA Ventures- TCThe Nature Conservancy
- UCUniversity of California
- SDSan Diego
Ownership
Estimated cap table from Dealroom's shareholder data — share of equity by holder. Stakes as last recorded by Dealroom (2026). Percentages are indicative.
Some investors are hidden on this public profile. See the full cap table on Dealroom →
Source: Dealroom Talent Intelligence.
Global footprint
team presence
across markets
Patents
6 active patent families included in this estimate.
A patent family groups patent filings for the same invention. Source: Dealroom · PatSnap.
Market sentiment
An AI-synthesised read of the highest-engagement posts about Enveda Biosciences on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Enveda Biosciences on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.